235 Participants NeededMy employer runs this trial

OviTex PRS for Breast Reconstruction

(RESTORE Trial)

Recruiting at 1 trial location
SC
Overseen BySenior Clinical Project Manager
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new treatment called OviTex PRS, a surgical mesh, to determine its safety and effectiveness for women undergoing implant-based breast reconstruction. It targets women having their first breast reconstruction immediately after a mastectomy, either due to cancer or as a preventive measure. Ideal candidates are non-smokers without previous breast surgeries, such as augmentation or reduction. The trial excludes individuals with certain health conditions or those on medications that affect healing. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research in breast reconstruction.

Do I need to stop my current medications for the trial?

The trial protocol does not specify if you need to stop taking your current medications. However, if you are taking medications that affect wound healing or increase postoperative risks, you may not be eligible to participate.

What prior data suggests that OviTex PRS is safe for breast reconstruction?

Research has shown that OviTex PRS, a special mesh made from sheep tissue, is generally safe for breast reconstruction. Studies indicate it functions similarly to other materials used in these surgeries, such as those made from human skin. In one study, about 22% of patients required additional surgery, often due to implant exposure or infection. Despite these risks, this treatment remains a safe and effective option for many undergoing breast reconstruction.12345

Why are researchers excited about this trial?

Unlike the standard of care for breast reconstruction, which often includes materials like silicone or saline implants, OviTex PRS is unique because it uses a biologic mesh derived from natural tissue. This mesh is designed to integrate more seamlessly with the body's own tissue, potentially enhancing healing and reducing the risk of complications. Researchers are excited about OviTex PRS because it offers a more natural repair method that could lead to better outcomes and faster recovery times for patients undergoing breast reconstruction.

What evidence suggests that OviTex PRS is effective for breast reconstruction?

Research has shown that OviTex PRS, a mesh made from sheep tissue, is effective for breast reconstruction. In studies comparing OviTex to other materials like STRATTICE, patients experienced softer breast implants, as measured by Baker grades. Another study found that OviTex performed as well as materials made from human tissue, offering a more affordable option for reconstruction. Patients using OviTex achieved similar success in reconstruction, proving it a reliable choice for those needing implant-based breast reconstruction.12356

Are You a Good Fit for This Trial?

This trial is for women aged 22 to 75 who are having their first immediate breast reconstruction with implants after a mastectomy, either due to cancer or to prevent it. Participants must not be current smokers and need to agree to follow study procedures.

Inclusion Criteria

I am a woman aged between 22 and 75.
I am scheduled for my first breast reconstruction with implants right after mastectomy.
I am willing and able to follow the study's requirements.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo implant-based breast reconstruction using OviTex PRS

8-12 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • OviTex PRS

Trial Overview

The study is testing the safety and effectiveness of OviTex PRS, a surgical mesh used during implant-based breast reconstruction. All participants will receive this product as part of their surgery.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: OviTex PRSExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Tela Bio Inc

Lead Sponsor

Trials
3
Recruited
450+

Citations

A Comparison of Ovine-Reinforced Hybrid Mesh (OviTex PRS ...

Fifty-nine of 89 breasts (66.3%) were treated with OviTex and 30 (33.7%) were treated with STRATTICE. All patients experienced a reduction in Baker grades. In ...

NCT07135596 | Effectiveness and Safety of OviTex® PRS ...

The purpose of this study is to evaluate the safety and effectiveness of OviTex PRS in subjects undergoing implant-based breast reconstruction. Official ...

3.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/39526814/

The Use of Reinforced Ovine Mesh in Implant Breast ...

This study supports the use of Ovitex as a cost-effective substitute for human acellular dermal matrices in implant breast reconstruction.

The Use of Reinforced Ovine Mesh in Implant Breast...

This study demonstrates that the use of Ovitex PRS (ovine reinforced extracellular matrix) is associated with statistically equivalent outcomes compared with ...

A Comparison of Ovine-Reinforced Hybrid Mesh (OviTex ...

RESULTS: Fifty-nine of 89 breasts (66.3%) were treated with OviTex and 30 (33.7%) were treated with STRATTICE. All patients experienced a reduction in Baker ...

The Effects of Ovine-Derived Reinforced Tissue Matrix ...

Overall, studies have shown rates of up to 20% in breast augmentation and 30% in breast reconstruction [15,16]. The development of standardized pre-clinical ...